8-K: Patterson Companies Reports Mixed Fiscal 2024 Results, Issues 2025 Guidance

Patterson Companies' fiscal 2024 fourth quarter saw a slight increase in net sales but a decrease in internal sales, impacted by a cybersecurity attack, while the company issued its fiscal 2025 earnings guidance.

Summary

• Patterson Companies reported a 0.1% year-over-year increase in net sales for the fourth quarter of fiscal 2024, reaching $1.72 billion, but internal sales decreased by 0.5%.
• The company's fourth-quarter internal sales were boosted by strong growth in production animal and dental consumables, which grew by 3.7% year-over-year.
• Patterson returned $327.9 million to shareholders in fiscal 2024 through dividends and share repurchases.
• Fourth-quarter GAAP earnings were $0.74 per diluted share, and adjusted earnings were $0.82 per diluted share, both negatively impacted by $0.04 per diluted share due to a cybersecurity attack on Change Healthcare.
• Fiscal 2024 GAAP earnings reached $1.98 per diluted share, and adjusted earnings were $2.30 per diluted share.
• The company has issued fiscal 2025 GAAP earnings guidance of $2.00 to $2.10 per diluted share and adjusted earnings guidance of $2.33 to $2.43 per diluted share.
• Full-year fiscal 2024 net sales totaled $6.57 billion, a 1.5% increase year-over-year, with internal sales up 0.8%.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative due to mixed results, with positive growth in some areas offset by declines in others and the impact of a cybersecurity incident. The forward guidance is positive but not overly optimistic.

Positives

• The company experienced strong growth in the production animal business.
• Dental consumables saw a 3.7% increase in internal sales for the fourth quarter.
• Patterson returned a significant amount of capital to shareholders, totaling $327.9 million in fiscal 2024.
• The company's full-year net sales increased by 1.5% to $6.57 billion.
• The Animal Health segment saw a 15% increase in value-added services in the fourth quarter.

Negatives

• Internal sales decreased by 0.5% in the fourth quarter.
• The cybersecurity attack on Change Healthcare negatively impacted both GAAP and adjusted earnings by $0.04 per diluted share in the fourth quarter.
• Dental segment internal sales decreased by 3.8% in the fourth quarter.
• Equipment sales decreased in both the Dental and Animal Health segments.
• Free cash flow declined by $8.6 million in fiscal 2024 compared to fiscal 2023.

Risks

• The company is dependent on suppliers for the products they sell.
• There is a risk of disruption in distribution capabilities.
• The company relies on sales representatives and service technicians to retain customers.
• There are risks associated with selling private label products.
• The company faces the risk of technological and market obsolescence.
• Cybersecurity attacks pose a risk to the company's information systems.
• The company is exposed to risks in the animal production business, including changing consumer demand and weather conditions.
• The company is exposed to risks in the health care industry, including changes in demand due to political, economic, and regulatory influences.
• There are risks of litigation and government inquiries and investigations.
• The company faces risks inherent in international operations, including currency fluctuations.

Future Outlook

Patterson Companies initiated its fiscal 2025 earnings guidance, expecting GAAP earnings in the range of $2.00 to $2.10 per diluted share and non-GAAP adjusted earnings in the range of $2.33 to $2.43 per diluted share.

Management Comments

• Don Zurbay, President and CEO of Patterson Companies, stated that the company navigated a challenging market environment while making progress on strategic objectives.
• He noted that fourth-quarter results were driven by strong performances in dental consumables and production animal businesses.
• Management expressed confidence in their strategy focused on investing to drive enhanced growth and profitability over the long term.

Industry Context

The results reflect the challenges in the dental and animal health supply markets, including the impact of cybersecurity incidents and market fluctuations. The company's focus on strategic objectives and investments aligns with industry trends towards long-term growth and profitability.

Comparison to Industry Standards

• Patterson's 0.1% net sales growth in Q4 is below the average growth rate of some of its competitors in the distribution sector, such as Henry Schein, which has shown stronger growth in recent quarters.
• The 3.7% growth in dental consumables is a positive sign, but the 11.9% decline in equipment sales is a concern, especially when compared to companies like Dentsply Sirona, which have seen more stable equipment sales.
• The impact of the cybersecurity attack on Change Healthcare highlights the vulnerability of the healthcare supply chain, a risk that other companies in the sector also face.
• Patterson's free cash flow of $171.3 million is lower than some of its peers, indicating potential challenges in operational efficiency and capital management.
• The company's guidance for fiscal 2025 is conservative, reflecting the current market conditions and the need for strategic investments to drive future growth.

Stakeholder Impact

• Shareholders will be impacted by the mixed financial results and the company's share repurchase and dividend programs.
• Employees may be affected by the company's strategic changes and performance.
• Customers will be impacted by the company's product offerings and service levels.
• Suppliers will be affected by the company's purchasing decisions and relationships.
• Creditors will be impacted by the company's financial performance and debt management.

Next Steps

• The company will hold a conference call to discuss the results.
• Patterson will focus on executing its strategic objectives to drive long-term growth and profitability.
• The company will continue to invest in its business and manage its capital allocation.

Key Dates

Keywords

Patterson Companies, Financial Results, Dental Consumables, Animal Health, Net Sales, Earnings, Cybersecurity, Share Repurchase, Dividends, Guidance